CD8+ αβ+ T Cells That Lack Surface CD5 Antigen Expression Are a Major Lymphotactin (XCL1) Source in Peripheral Blood Lymphocytes

Journal of Immunology

Volumn 171, Issue 9, 2003, Pages 4528-4538

  Stievano, Laura ^a   Tosello, Valeria ^a   Marcato, Novella ^a   Rosato, Antonio ^a   Sebelin, Annalisa ^a   Chieco Bianchi, Luigi ^a   Amadori, Alberto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; FRACTALKINE; LYMPHOTACTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PADGEM PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CELL COMPARTMENTALIZATION; CELL MIGRATION; CELL PROLIFERATION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; LEUKOCYTE FUNCTION; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TARGET CELL;

EID: 0142211168     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.9.4528     Document Type: Article

References (69)

1. Baggiolini M. 1998. Chemokines and leukocyte traffic. Nature 392:565.
2. Baggiolini, M. 2001. Chemokines in pathology and medicine. J. Intern. Med. 250:91.
3. Mantovani, A. 1999. Chemokines. Introduction and overview. Chem. Immunol. 72:1.
4. Zlotnik, A. and O. Yoshie. 2000. Chemokines: A new classification system and their role in immunity. Immunity 12:121.
5. Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55:97.
6. Rollins, B. J. 1997. Chemokines. Blood 90:909.
7. Hedrick, A. J., V. Sailor, D. Figueroa, L. Mizoue, Y. Xu, S. Menon, J. Abrams, T. Handel, and A. Zlotnik. 1997. Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. J. Immunol. 158:1533.
8. Hedrick, A. J., and A. Zlotnik. 1998. Molecule of the month: lymphotactin. Clin. Immunol. Immunopathol. 87:218.
9. Bianchi, G., S. Sozzani, A. Zlotnick, A. Mantovani, and P. Allavena. 1996. Migratory response of human natural killer cells to lymphotactin. Eur. J. Immunol. 26:3238.
10. Huang, H., F. Li, C. M. Cairns, J. R. Gordon, and J. Xiang. 2001. Neutrophilis and B cells express XCR1 receptor and chemotactically respond to lymphotactin. Biochem. Biophys. Res. Commun. 281:378.
11. Kelner, G. S., J. Kennedy, K. B. Bacon, S. Kleyensteuber, D. A. Largaespada, N. A. Jenkins, N. G. Copeland, J. F. Bazan, K. W. Moore, T. J. Schall, et al. 1994. Lymphotactin: a cytokine that represent a new class of chemokine. Science 266:1395.
12. + T lymphocytes. Eur. J. Immunol. 25:1744.
13. Inngjerdingen, M., B. Damaj, and A. A. Maghazachi. 2001. Expression and regulation of chemokine receptors in human natural killer cells. Blood 97:367.
14. Kennedy, J., A. P. Vicari, V. Saylor, S. M. Zurawski, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and A. Zlotnik. 2000. A molecular analysis of NKT cells: identification of a class-1 restricted T cell-associated molecule (CRTAM). J. Leukocyte Biol. 67:725.
15. Vissers, J. L. M., F. C. Hartgers, E. Lindhout, M. B. M. Teunissen, C. G. Figdor, and G. J. Adema. 2001. Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo. J. Leukocyte Biol. 69:785.
16. Rumsaeng, V., H. Vliagoftis, C. K. Oh, and D. D. Metcalfe. 1997. Lymphotactin gene expression in mast cells following Fcε receptor I aggregation. J. Immunol. 158:1353.
17. Boismenu, R., L. Feng, Y. Y. Xia, J. C. C. Chang, and W. L. Havran. 1996. Chemokines expression by intraepithelial γδ T cells: implications for the recruitment of inflammatory cells to damage epithelia. J. Immunol. 157:985.
18. Cipriani, B., G. Borsellino, F. Poccia, R. Placido, D. Tramonti, S. Bach, L. Battistini, and C. F. Brosnam. 2000. Activation of C-C β-chemokines in human peripheral blood γδ T cells by isopentenyl pyrophosphate and regulation by cytokines. Chemokines. 95:39.
19. + T cells. Cytokine 16:73.
20. h2-polarized cells. Int. Immunol. 13:367.
21. Zhang, S., N. W. Lukacs, V. A. Lawless, S. L. Kunkel, and M. H. Kaplan. 2000. Differential expression of chemokines in Th1 and Th2 cells is dependent on Stat6 but not Stat4. J. Immunol. 165:10.
22. + T cells. Blood 96:420.
23. Dorner, B. G., A. Scheffold, M. S. Rolph, M. B. Huser, S. H. E. Kaufmann, A. Radbruch, I. E. A. Flesch, and R. A. Kroczek. 2002. MIP-1α, MIP-1β, RANTES, and ATAC/lymphotactin function together with IFN-γ as type 1 cytokines. Proc. Natl. Acad. Sci. USA 99:6181.
24. lo cells in vitro and in vivo. Cell. Immunol. 209:83.
25. Lillard, J. W., P. N. Boyaka, J. A. Hedrick, A. Zlotnik, and J. R McGhee. 1999. Lymphotactin acts as an innate mucosal adjuvant. J. Immunol. 162:1959.
26. Dilloo, D., K. Bacon, W. Holden, W. Zhong, S. Burdach, A. Zlotnik, and M. Brenner. 1996. Combined chemokine and cytokine gene transfer enhances antitumor immunity. Nat. Med. 2:1090.
27. Emtage, P. C. R., Y. Wan, M. Hitt, F. L. Graham, W. J. Muller, A. Zlotnik, and J. Gauldie. 1999. Adenoviral vectors expressing lymphotactin and interleukin-12 sinergize to facilitate tumor regression in murine breast cancer models. Hum. Gene Ther. 10:697.
28. Cao, X., W. Zhang, L. He, Z. Xie, S. Ma, Q. Tao, Y. Yu, H. Hamada, and J. Wang. 1998. Lymphotactin gene-modified bone marrow dendritic cells act as potent adjuvants for peptide delivery to induce specific antitumor immunity. J. Immunol. 161:6238.
29. Zhang, W., L. He, Z. Yuan, Z. Xie, J. Wang, H. Hamada, and X. Cao. 1999. Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cell after genetic modification with lymphotactin. Hum. Gene Ther. 10:1151.
30. Silvestri, B., F. Calderazzo, V. Coppola, A. Rosato, S. Iacobelli, C. Natoli, A. Ullrich, I. Sures, M. Azam, C. Brakebush, et al. 1998. Differential effect on TCR:CD3 stimulation of a 90kD glycoprotein (gp90/Mac-2BP). a member of the scavenger receptor cysteine-rich domain protein family. Clin. Exp. Immunol. 113:394.
31. Coppola, V., A. Veronesi, S. Indraccolo, F. Calderazzo, M. Mion, S. Minuzzo. G. Esposito, D. Mauro, B. Silvestri, P. Gallo, et al. 1998. Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. IV. Differential activation of human Th-1 and Th-2 lymphocytes and influence of the atopic status on lymphoma development. J. Immunol. 160:2514.
32. Indraccolo, S., S. Minuzzo, R. Zamarchi, F. Calderazzo, E. Piovan, and A. Amadori. 2002. Alternatively spliced forms of Igα and Igβ prevent B cell receptor expression on the cell surface. Eur. J. Immunol. 32:1530.
33. Indraccolo, S., E. Gola, A. Rosato, W. Habeler, V. Tisato, V. Roni, G. Esposito, M. Morini, A. Albini, D. M. Noonan, et al. 2002. Differential effects of angiostatin, endostatin and interferon-α1 gene transfer on in vivo growth of human breast cancer cells. Gene Ther. 9:867.
34. Indraccolo, S., W. Habeler, V. Tisato, L. Stievano, E. Piovan, V. Tosello, G. Esposito, R. Wagner, K. Uberla, L. Chieco-Bianchi, et al. 2002. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors. Cancer Res. 62:6099.
35. Zhan, Y., X. Song, and G. W. Zhou. 2001. Structural analysis of regulatory protein domains using GST-fusion proteins. Gene 281:1.
36. Amadori, A., R. Zamarchi, M. L. Veronese, M. Panozzo, A. Barelli, A. Borri, M. Sironi, F. Colotta, A. Mantovani, and L. Chieco-Bianchi. 1991. B cell activation during HIV-1 infection. II. Cell-to-cell interactions and cytokine requirement. J. Immunol. 146:57.
37. Amadori, A., R. Zamarchi, G. De Silvestre, G. Forza, G. Cavattoni, G. A. Danieli, M. Clementi, and L. Chieco-Bianchi. 1995. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat. Med. 1:1279.
38. + individuals. Blood 92:198.
39. + T cells via an IL-2-dependent mechanism. Eur. J. Immunol. 29:2443.
40. + T cell population lacking CD5 antigen expression is expanded in peripheral blood of human immunodeficiency virus-infected patients. Clin. Immunol. Immunopathol. 77:253.
41. Trejdosiewicz, L. K., C. J. Smart, D. J. Oakes, P. D. Howdle, G. Malizia, D. Campana, and A. W. Boylston. 1989. Expression of T-cell receptors TcR1 (γ/δ) and TcR2 (α/β) in the human intestinal mucosa. Immunology. 68:7.
42. Bierer, B. E., Y. Nishimura, S. J. Burakoff, and B. R. Smith. 1988. Phenotypic and functional characterization of human cytolytic T cells lacking expression of CD5. J. Clin. Invest. 81:1390.
43. Moebius, U., G. Kober, A. L. Griscelli, T. Hercend, and S. C. Meuer. 1991. Expression of different CD8 isoforms on distinct human lymphocyte subpopulations. Eur. J. Immunol. 21:1793.
44. Norment, A. M., and D. R. Littman. 1988. A second subunit of CD8 is expressed in human T cells. EMBO J. 7:3433.
45. Azzam, H. S., A. Grinberg, K. Lui, H. Shen, E. W. Shores, and P. E. Love. 1998. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 188:2301.
46. Chan, S., C. Waltzinger, A. Tarakhovsky, C. Benoist, and D. Mathis. 1999. An influence of CD5 on the selection of CD4-lineage T cells. Eur. J. Immunol. 29:2916.
47. + thymocytes and supports their differentiation to the CD4 lineage. J. Immunol. 164:1260.
48. Yoshida, T., T. Imai, M. Kakizaki, M. Nishimura, S. Takagi, and O. Yoshie, 1998. Identification of a single C motif-1/lymphotactin receptor XCR1. J. Biol. Chem. 273:16551.
49. Cairns, C. M., J. R. Gordon, F. Li, M. E. Baca-Estrada, T. Moyana, and J. Xiang. 2001. Lymphotactin expression by engineered myeloma cells drives tumor regression: mediation by CD4 and CD8 T cells and neutrophils expressing XCR1 receptor. J. Immunol. 167:57.
50. Xia, D. J., W. P. Zhang, S. Zheng, J. Wang, J. P. Pan, Q. Wang, L. H. Zhang, H. Hamada, and X. Cao. 2002. Lymphotactin cotransfection enhances the therapeutic efficacy of dendritic cells genetically modified with melanoma antigen gp100. Gene Ther. 9:592.
51. - lymphotactin transgene expression. Cancer Res. 62:2043.
52. Middel, P., P. Thelen, S. Blaschke, F. Polzien, K. Reich, V. Blaschke, A. Wrede, K. Mathias-Hummel, B. Gunawan, and H.-J. Radzun. 2001. Expression of the T-cell chemoattractant chemokine lymphotactin in Crohn's disease. Am. J. Pathol. 159:1751.
53. Ou, Z. L., O. Hotta, Y. Natori, H. Sugai, Y. Taguma, and Y. Natori. 2002. Enhanced expression of C chemokine lymphotactin in IgA nephropathy. Nephron 91:262.
54. Wang, J.-D., N. Nonomura, S. Takahara, B.-S. Li, H. Azuma, N. Ichimaru, Y. Kokado, K. Matsumiya, T. Miki, S. Suzuki, et al. 1998 Lymphotactin: a key regulator of lymphocyte trafficking during acute graft rejection. Immunology 95:56.
55. Yun, J. J., M. P. Fischbein, H. Laks, M. C. Fischbein, M. L. Espejo, K. Ebrahimi, Y. Irie, J. Berliner, and A. Ardehali. 2000. Early and late chemokine production correlates with cellular recruitment in cardiac allograft vasculopathy. Transplantation 69:2515.
56. Ou, Z. L., Y. Natori, and Y. Natori. 2000. Transient and sequential expression of chemokine mRNA in glomeruli in puromycin aminonucleoside nephrosis. Nephron 85:254.
57. + T cells. Blood 97:2205.
58. Cristillo, A. D., M. J. Macri, and B. E. Bierer. 2003. Differential chemokine expression profiles in human peripheral blood T lymphocytes: dependence on T-cell coreceptor and calcineurin signaling. Blood 101:216.
59. Hautamaa, D., R. Merica, Z. Cheng, and M. K. Jenkins. 1997. Murine lymphotactin: gene structure, post-translational modification and inhibition of expression by CD28 costimulation. Cytokine 9:375.
60. Bierer, B. E., S. J. Burakoff, and B. R. Smith. 1989. A large proportion of T lymphocytes lack CD5 expression after bone marrow transplantation. Blood 73:1359.
61. - lymphocyte subpopulation after autologous bone marrow transplantation and chemotherapy. J. Clin. Pathol. 44:259.
62. Terry, L. A., J. P. DiSanto, T. N. Small, and N. Flomenberg. 1990. Differential expression and regulation of the human CD8α and CD8β chains. Tissue Antigens 35:82.
63. Baume, D. M., M. A. Caligiuri, T. J. Manley, J. F. Daley, and J. Ritz. 1990. Differential expression of CD8α and CD8β associated with MHC-restricted and non-MHC-restricted cytolytic effector cells. Cell. Immunol. 131:352.
64. Pantaleo, G., and A. S. Fauci. 1995. New concepts in the immunopathogenesis of HIV infection. Annu. Rev. Immunol. 13:487.
65. + CD8 αβ IEL do not represent separate T cell lineages. Eur. J. Immunol. 27:1756.
66. + peripheral blood leukocytes mediating cytotoxic T-lymphocyte activity during human immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA 90:9427.
67. + T-cell apoptosis in patients with acute herpesvirus infections: loss of costimulatory molecules CD28, CD5 and CD6 but relative maintenance of Bax and Bcl-X expression. Immunology 88:508.
68. - cells in cats infected with feline immunodeficiency virus. J. Gen. Virol. 79:91.
69. - T lymphocytes in renal transplant recipients. Clin. Lab. Haematol. 13:335.